Cullinan Therapeutics
(NASDAQ:CGEM)
$21.63
-0.08[-0.37%]
At close: Jun 12
$21.63
0[0.00%]
PreMarket: 4:29PM EDT
Consensus Rating1
Buy
Highest Price Target1
$40.00
Lowest Price Target1
$19.00
Consensus Price Target1
$22.67

Cullinan Therapeutics Stock (NASDAQ:CGEM), Analyst Ratings, Price Targets, Predictions

Cullinan Therapeutics Inc has a consensus price target of $22.67, established from looking at the 26 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and Wedbush on June 3, 2024, May 24, 2024, and May 16, 2024. With an average price target of $30.67 between HC Wainwright & Co., HC Wainwright & Co., and Wedbush, there's an implied 41.78% upside for Cullinan Therapeutics Inc from these 3 analyst ratings.

Analyst Trend
1
Feb
0
0
0
0
Mar
1
Apr
1
May
0
0
0
0
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.4
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Wedbush
Stifel
JonesTrading
BTIG

1calculated from analyst ratings

Analyst Ratings for Cullinan Therapeutics

Buy NowGet Alert
06/03/2024Buy Now29.45%HC Wainwright & Co.
Edward White
$28 → $28ReiteratesBuy → BuyGet Alert
05/24/2024Buy Now29.45%HC Wainwright & Co.
Edward White
→ $28ReiteratesBuy → BuyGet Alert
05/16/2024Buy Now66.44%Wedbush
Robert Driscoll
→ $36ReiteratesOutperform → OutperformGet Alert
05/16/2024Buy Now29.45%HC Wainwright & Co.
Edward White
$29 → $28MaintainsBuyGet Alert
05/01/2024Buy Now84.93%Stifel
Bradley Canino
→ $40Initiates → BuyGet Alert
04/17/2024Buy Now20.2%JonesTrading
Soumit Roy
$22 → $26MaintainsBuyGet Alert
04/17/2024Buy Now38.7%BTIG
Kaveri Pohlman
$20 → $30MaintainsBuyGet Alert
04/16/2024Buy Now34.07%HC Wainwright & Co.
Edward White
$34 → $29MaintainsBuyGet Alert
04/15/2024Buy NowWilliam Blair
Matt Phipps
Initiates → OutperformGet Alert
03/14/2024Buy Now57.19%HC Wainwright & Co.
Edward White
→ $34ReiteratesBuy → BuyGet Alert
02/15/2024Buy Now38.7%Wedbush
Robert Driscoll
→ $30Initiates → OutperformGet Alert
10/06/2023Buy Now1.71%JonesTrading
Soumit Roy
→ $22Initiates → BuyGet Alert
08/11/2023Buy Now57.19%HC Wainwright & Co.
Edward White
$49 → $34ReiteratesBuy → BuyGet Alert
08/09/2023Buy Now126.54%HC Wainwright & Co.
Edward White
→ $49Reiterates → BuyGet Alert
07/07/2023Buy Now126.54%HC Wainwright & Co.
Edward White
→ $49ReiteratesBuy → BuyGet Alert
06/15/2023Buy NowTD Cowen
Marc Frahm
Initiates → OutperformGet Alert
06/05/2023Buy Now126.54%HC Wainwright & Co.
Edward White
→ $49ReiteratesBuy → BuyGet Alert
05/26/2023Buy Now126.54%HC Wainwright & Co.
Edward White
→ $49ReiteratesBuy → BuyGet Alert
05/12/2023Buy Now126.54%HC Wainwright & Co.
Edward White
$50 → $49MaintainsBuyGet Alert
03/27/2023Buy Now131.16%HC Wainwright & Co.
Edward White
→ $50Reiterates → BuyGet Alert
03/10/2023Buy Now131.16%HC Wainwright & Co.
Edward White
→ $50Reiterates → BuyGet Alert
02/15/2023Buy Now131.16%HC Wainwright & Co.
Edward White
→ $50Reiterates → BuyGet Alert
02/03/2023Buy Now-12.16%Morgan Stanley
Jeffrey Hung
$27 → $19MaintainsOverweightGet Alert
11/21/2022Buy Now-7.54%BTIG
Kaveri Pohlman
→ $20Initiates → BuyGet Alert
05/13/2022Buy Now15.58%SVB Leerink
Andrew Berens
$36 → $25MaintainsOutperformGet Alert
03/18/2022Buy Now145.03%HC Wainwright & Co.
Edward White
$55 → $53MaintainsBuyGet Alert

FAQ

Q

What is the target price for Cullinan Therapeutics (CGEM) stock?

A

The latest price target for Cullinan Therapeutics (NASDAQ:CGEM) was reported by HC Wainwright & Co. on June 3, 2024. The analyst firm set a price target for $28.00 expecting CGEM to rise to within 12 months (a possible 29.45% upside). 16 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Cullinan Therapeutics (CGEM)?

A

The latest analyst rating for Cullinan Therapeutics (NASDAQ:CGEM) was provided by HC Wainwright & Co., and Cullinan Therapeutics reiterated their buy rating.

Q

When was the last upgrade for Cullinan Therapeutics (CGEM)?

A

There is no last upgrade for Cullinan Therapeutics

Q

When was the last downgrade for Cullinan Therapeutics (CGEM)?

A

There is no last downgrade for Cullinan Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Cullinan Therapeutics (CGEM)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cullinan Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cullinan Therapeutics was filed on June 3, 2024 so you should expect the next rating to be made available sometime around June 3, 2025.

Q

Is the Analyst Rating Cullinan Therapeutics (CGEM) correct?

A

While ratings are subjective and will change, the latest Cullinan Therapeutics (CGEM) rating was a reiterated with a price target of $28.00 to $28.00. The current price Cullinan Therapeutics (CGEM) is trading at is $21.63, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch